Elizabeth Dreyer Joins Amyris, Inc. as Chief Accounting Officer & Corporate Controller, Effective October 11, 2022
September 14, 2022 at 08:58 am EDT
Share
On September 9, 2022, Elizabeth Dreyer agreed to join Amyris, Inc. as its Chief Accounting Officer & Corporate Controller, reporting to Han Kieftenbeld, the Company's Chief Financial Officer, effective October 11, 2022. Ms. Dreyer, 59, has over 20 years of U.S. public company accounting experience with more than 10 years of experience as Chief Accounting Officer of public companies. Most recently, she served as Chief Accounting
Officer of Travel + Leisure Co., a publicly-traded global provider of hospitality services and travel products and Wyndham spin-off, from June 2018 until September 2022, after joining Wyndham Worldwide Corp. in March 2018.
Previously, Ms. Dreyer served as Vice President, Controller and Chief Accounting Officer of Edgewell Personal Care Company, a manufacturer and marketer of consumer products, from January 2015 to March 2018. Prior to Edgewell, Ms. Dreyer was Vice President, Controller and Chief Accounting Officer of Hillenbrand Inc. from October 2010 to January 2015. Prior to that, she was Vice President of Finance with Zimmer Corp., Chief
Financial Officer of Createc Corporation, and Vice President of Organizational Effectiveness of ADESA, Inc. Ms. Dreyer began her career with Deloitte & Touche LLP in its assurance services practice. She is a Certified
Public Accountant and a Chartered Global Management Accountant. Ms. Dreyer holds a Bachelor of Science degree in Business from Indiana University, Bloomington.
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Companyâs sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
AMYRIS, INC. 
